Groups | Dose (mg/kg) | Hb (g/dL) | HbA1c (%) | Serum insulin (μIU/mL) | TP (g/dL) |
Control | Vehicle | 13.74 ± 1.03 | 6.12 ± 0.12 | 9.15 ± 0.15 | 7.22 ± 0.24 |
Diabetic control | Vehicle | 7.62 ± 1.24a | 12.05 ± 0.33a | 4.67 ± 0.15a | 4.99 ± 0.19a |
HAFE | 100 | 10.98 ± 0.28b | 7.32 ± 0.15b | 6.64 ± 0.17b | 5.82 ± 0.52b |
HAFE | 200 | 11.67 ± 0.33b | 8.23 ± 0.17b | 7.59 ± 0.33b | 6.88 ± 0.73c |
HALE | 100 | 10.53 ± 0.42b | 7. 54 ± 0.16b | 6.84 ± 0.71b | 5.89 ± 0.31b |
HALE | 200 | 12.13 ± 0.18b | 8.43 ± 0.22b | 7. 72 ± 0.22 | 6.72 ± 0.22c |
Glibenclamide (Standard) | 5 | 12.94 ± 0.23b | 6.75 ± 0.16b | 8.15 ± 0.54 | 6.55 ± 0.41c |